down arrow

Brooks Lab.

28
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE650L01011
  • NSEID: BROOKS
  • BSEID: 533543
INR
126.50
1.65 (1.32%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 27.56 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Brooks Lab. Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
Profit Before Tax
-19.00
-38.00
-23.00
-8.00
Adjustment
22.00
12.00
11.00
10.00
Changes In working Capital
-13.00
11.00
-24.00
7.00
Cash Flow after changes in Working Capital
-9.00
-14.00
-37.00
8.00
Cash Flow from Operating Activities
-9.00
-14.00
-37.00
4.00
Cash Flow from Investing Activities
0.00
0.00
-24.00
-5.00
Cash Flow from Financing Activities
9.00
11.00
64.00
1.00
Net Cash Inflow / Outflow
0.00
-2.00
1.00
0.00
Opening Cash & Cash Equivalents
0.00
2.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
2.00
0.00
Compare Cash Flow Results of Brooks Lab.
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-19.57
2399.36
-2,418.00
-100.82%
Adjustment
22.76
212.2
-190.00
-89.27%
Changes In working Capital
-13.07
20.42
-33.00
-164.01%
Cash Flow after changes in Working Capital
-9.88
2631.98
-2,640.00
-100.38%
Cash Flow from Operating Activities
-9.68
2152.45
-2,161.00
-100.45%
Cash Flow from Investing Activities
0.18
-2080.52
2,080.00
100.01%
Cash Flow from Financing Activities
9.6
5.27
4.00
82.16%
Net Cash Inflow / Outflow
0.1
77.19
-77.00
-99.87%
Opening Cash & Cash Equivalents
0.02
304.82
-304.00
-99.99%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0.13
382.01
-382.00
-99.97%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 33.20% vs 61.30% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
-9.68
-14.49
33.20%